At the turn of the new year, the final drug cost reduction for Medicare Part D beneficiaries went into effect, effectively closing the notorious Part D doughnut hole, according to an article published in the New York Times.
However, while the coverage gap has been closed, Kaiser Family Foundation’s Tricia Neuman says the issue of patients being exposed to high drug costs is yet to be fully resolved.
“It’s great that the doughnut hole is closing,” Neuman said. “But people will continue to be exposed to very high drug costs without Congressional action.”
To read the full article on the New York Times, click here. (Paid subscription may be required)